GILEAD SCIENCES, INC. Diversified Active

CIK: 0000882095 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 12, 2026

Total Value ($000): $1,935,508 (100.0% shares, 0.0% debt)

Holdings (6)

Exited Positions (3)

— MERUS N V 2.2%

Value ($000) $42,605 Shares 452,527 Est. Cost $42.05 Unrealized —

TNGX TANGO THERAPEUTICS INC 2.1%

Value ($000) $40,777 Shares 4,854,443 Est. Cost $4.64 Unrealized +85.6%

CYPH LEAP THERAPEUTICS INC 0.1%

Value ($000) $2,415 Shares 5,319,148 Est. Cost $2.97 Unrealized -63.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	452,527	$42,605	2.2%	$42.05	—	—	N5749R100
TNGX	TANGO THERAPEUTICS INC	4,854,443	$40,777	2.1%	$4.64	+85.6%	—	87583X109
CYPH	LEAP THERAPEUTICS INC	5,319,148	$2,415	0.1%	$2.97	-63.2%	—	52187K200

Unchanged Positions (6)

RCUS ARCUS BIOSCIENCES INC 38.7%

Value ($000) $748,852 Shares 31,424,760 Est. Cost $16.13 Unrealized +26.5%

ACLX ARCELLX INC 22.6%

Value ($000) $438,196 Shares 6,720,803 Est. Cost $86.39 Unrealized -7.7%

ASMB ASSEMBLY BIOSCIENCES INC 7.9%

Value ($000) $153,228 Shares 4,505,391 Est. Cost $19.07 Unrealized +68.9%

GLPG GALAPAGOS NV 28.4%

Value ($000) $550,616 Shares 16,707,477 Est. Cost $27.64 Unrealized —

KYTX KYVERNA THERAPEUTICS INC 2.0%

Value ($000) $38,786 Shares 4,126,119 Est. Cost $4.79 Unrealized +55.0%

XLO XILIO THERAPEUTICS INC 0.3%

Value ($000) $5,829 Shares 9,105,451 Est. Cost $0.98 Unrealized -23.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RCUS	ARCUS BIOSCIENCES INC	31,424,760	$748,852	38.7%	$16.13	+26.5%	COM	03969F109
ACLX	ARCELLX INC	6,720,803	$438,196	22.6%	$86.39	-7.7%	COMMON STOCK	03940C100
ASMB	ASSEMBLY BIOSCIENCES INC	4,505,391	$153,228	7.9%	$19.07	+68.9%	COM NEW	045396207
GLPG	GALAPAGOS NV	16,707,477	$550,616	28.4%	$27.64	—	SPON ADR	36315X101
KYTX	KYVERNA THERAPEUTICS INC	4,126,119	$38,786	2.0%	$4.79	+55.0%	COM	501976104
XLO	XILIO THERAPEUTICS INC	9,105,451	$5,829	0.3%	$0.98	-23.6%	COM	98422T100